Works matching IS 25233548 AND DT 2021 AND VI 41 AND IP 2

Results: 10

Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2‐positive breast cancer: An open‐label, dose‐escalation, phase I study.
Published in:
Cancer Communications, 2021, v. 41, n. 2, p. 171, doi. 10.1002/cac2.12135
By:
- Hong, Ruoxi;
- Xia, Wen;
- Wang, Liye;
- Lee, Kaping;
- Lu, Qianyi;
- Jiang, Kuikui;
- Li, Shengfeng;
- Yu, Jinquan;
- Wei, Jin;
- Tang, Weijia;
- Zhou, Danyang;
- An, Xin;
- Huang, Jiajia;
- Xue, Cong;
- Bi, Xiwen;
- Shi, Yanxia;
- Yuan, Zhongyu;
- Xu, Fei;
- Wang, Shusen
Publication type:
Article
High‐throughput sequencing detection and ensartinib treatment of lung cancer harboring NTRK1 fusion.
Published in:
Cancer Communications, 2021, v. 41, n. 2, p. 192, doi. 10.1002/cac2.12133
By:
- Song, Zhengbo;
- Xu, Chunwei;
- Pu, Xingxiang;
- Zhu, Youcai;
- Wang, Wenxian;
- Li, Xingliang;
- Gao, Yanqiu;
- Zhu, Wenliang;
- He, Yunwei;
- Wu, Lin;
- Mao, Li;
- Chen, Li;
- Chen, Ming
Publication type:
Article
RNF114 suppresses metastasis through regulation of PARP10 in cervical cancer cells.
Published in:
Cancer Communications, 2021, v. 41, n. 2, p. 187, doi. 10.1002/cac2.12132
By:
- Zhao, Yahui;
- Liang, Xiao;
- Wei, Li;
- Liu, Yao;
- Liu, Juan;
- Feng, Huan;
- Zheng, Fen;
- Wang, Ying;
- Ma, Haijie;
- Wu, Jiaxue
Publication type:
Article
Dicer‐independent snRNA/snoRNA‐derived nuclear RNA 3 regulates tumor‐associated macrophage function by epigenetically repressing inducible nitric oxide synthase transcription.
Published in:
Cancer Communications, 2021, v. 41, n. 2, p. 140, doi. 10.1002/cac2.12131
By:
- Shi, Yang;
- Shi, Qingzhu;
- Shen, Qicong;
- Zhang, Qian;
- Cao, Xuetao
Publication type:
Article
S100A8 promotes epithelial‐mesenchymal transition and metastasis under TGF‐β/USF2 axis in colorectal cancer.
Published in:
Cancer Communications, 2021, v. 41, n. 2, p. 154, doi. 10.1002/cac2.12130
By:
- Li, Si;
- Zhang, Jun;
- Qian, Senmi;
- Wu, Xuesong;
- Sun, Liang;
- Ling, Tianyi;
- Jin, Yao;
- Li, Wenxiao;
- Sun, Lichao;
- Lai, Maode;
- Xu, Fangying
Publication type:
Article
Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer.
Published in:
Cancer Communications, 2021, v. 41, n. 2, p. 91, doi. 10.1002/cac2.12129
By:
- Huang, Hai‐Ming;
- Li, Hai‐Xia
Publication type:
Article
Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors.
Published in:
Cancer Communications, 2021, v. 41, n. 2, p. 183, doi. 10.1002/cac2.12128
By:
- Yang, Dafu;
- Li, Dan;
- Dai, Zhaoxia;
- Ma, Yutong;
- Ou, Qiuxiang;
- Wu, Xue;
- Cui, Saiqiong
Publication type:
Article
CRISPR/Cas9 screening identifies a kinetochore‐microtubule dependent mechanism for Aurora‐A inhibitor resistance in breast cancer.
Published in:
Cancer Communications, 2021, v. 41, n. 2, p. 121, doi. 10.1002/cac2.12125
By:
- Chen, Ailin;
- Wen, Shijun;
- Liu, Fang;
- Zhang, Zijian;
- Liu, Meiling;
- Wu, Yuanzhong;
- He, Bin;
- Yan, Min;
- Kang, Tiebang;
- Lam, Eric W‐F;
- Wang, Zifeng;
- Liu, Quentin
Publication type:
Article
LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer.
Published in:
Cancer Communications, 2021, v. 41, n. 2, p. 109, doi. 10.1002/cac2.12108
By:
- Tan, Yue‐Tao;
- Lin, Jin‐Fei;
- Li, Ting;
- Li, Jia‐Jun;
- Xu, Rui‐Hua;
- Ju, Huai‐Qiang
Publication type:
Article
Issue Information.
Published in:
Cancer Communications, 2021, v. 41, n. 2, p. 89, doi. 10.1002/cac2.12054
Publication type:
Article